THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The firm is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The company can also reduce the bacterial count of cannabis during the drying process. The firm also operates a portfolio of companies in genetics, cultivation, extraction, and distribution as well as specialty real estate and nutrients for commercial and hobby cannabis growers. These companies consist of Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, Shasta Properties Management, and Blue Sky Investments.
THCT stock price ended at $0 on Monday, after dropping 100.00%
On the latest trading day Mar 23, 2026, the stock price of THCT fell by 100.00%, dropping from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. On the latest trading day, the trading volume for THCT rose by -- shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 9.5K shares were traded, with a market value of approximately --.
THCT Technical Signals
Technical Signals Summary
Buy Signals 2
Neutral Signals 1
Sell Signals 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
THCT currently exhibits 2 buy signals and 4 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -100% during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for THCT
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for THCT. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to THCT?
According to technical analysis, THC Therapeutics Inc has an aggregate signal of Sell. THC Therapeutics Inc has 2 Buy signals, 1 Neutral Signals and 4 sell signals.
What are the Fibonacci retracement levels for THCT?
The Fibonacci retracement level for THC Therapeutics Inc is between 0% and 23.6%
What is the RSI for THC Therapeutics Inc?
The RSI for THC Therapeutics Inc is currently 44.97, indicating a neutral condition
What is THC Therapeutics Inc price for the next 12 months?
THC Therapeutics Inc THCT price for the next 12 months is estimated at $0.
How high is THC Therapeutics Inc expected to go?
According to wall street analysts, THC Therapeutics Inc is expected to reach a high forecast of $0.